11 completed, 3 unknown, 1 recruiting, 1 terminated. 6 Phase 1, 3 Phase 2, 3 Phase 4, 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 6 | Completed 6 |
| Phase 2 | 3 | Unknown 2, Completed 1 |
| Phase 4 | 3 | Completed 2, Recruiting 1 |
| Phase 3 | 2 | Completed 1, Terminated 1 |
Follow Antacids: new trials by email Literature Review of Antacids trials Research Report on Antacids
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Microbiota Transplant Therapy for Children With Both Autism Spectrum Disorder and Gastrointestinal Disorders MTP-101P, Vancomycin, Miralax - Autism Spectrum Disorder, Gastro-Intestinal Disorder | Phase 2 | Unknown | Gut-Brain-Axis Therapeutics Inc. | 60 | 2024-08-20 | 2024-09-25 |
| Microbiota Transfer Therapy for Children and Adults With Both Pitt Hopkins Syndrome and Gastrointestinal Disorders MTP-101P, Vancomycin, Magnesium Citrate - Pitt Hopkins Syndrome | Phase 2 | Unknown | Gut-Brain-Axis Therapeutics Inc. | 20 | 2024-02-27 | 2024-03-20 |
| Famotidine and Antacids for Treatment of Dyspepsia Intravenous Famotidine, Oral Maalox/ Mylanta - Dyspepsia, GERD | Phase 4 | Recruiting | Stony Brook University | 80 | 2023-11-09 | 2026-06-02 |
| A Study to Evaluate a New Tablet Formulation of Lu AG06466 in Healthy Participants Lu AG06466 Capsule, Lu AG06466 Tablet, Antacid - Healthy | Phase 1 | Completed | H. Lundbeck A/S | 16 | 2021-08-23 | 2022-01-21 |
| Management of Esophagitis Following Repair of Esophageal Atresia Antacids - Esophageal Atresia, Esophagitis | Unknown | Boston Children's Hospital | 50 | 2019-02-01 | 2021-09-10 | |
| A Study of the Drug Interactions Between Danicopan and Cyclosporine, Tacrolimus, Antacids, and Omeprazole in Healthy Adults Danicopan, Cyclosporine, Tacrolimus - Healthy | Phase 1 | Completed | Alexion Pharmaceuticals, Inc. | 72 | 2018-07-27 | 2021-11-05 |
| Evaluation of Rebound Effect After Withdrawal of Proton Pump Inhibitor in Geriatric Population Antacids - Proton Pump Inhibitor | Completed | Fondation Hôpital Saint-Joseph | 30 | 2017-06-10 | 2019-08-06 | |
| Doxepin and a Topical Rinse in the Treatment of Acute Oral Mucositis Pain in Patients Receiving Radiotherapy With or Without Chemotherapy doxepin hydrochloride oral solution, DLA (diphenhydramine, lidocaine and antacids) rinse, Placebo - Acute Oral Mucositis Pain | Phase 3 | Completed | Alliance for Clinical Trials in Oncology | 275 | 2014-11-18 | 2025-05-18 |
| Study Of Three Different Stomach Acid Reducing Agents When Given With Palbociclib (PD-0332991) And Food palbociclib commercial free base, famotidine, rabeprazole - Healthy | Phase 1 | Completed | Pfizer | 27 | 2014-04-01 | 2014-06-19 |
| Effect of Alendronate on Bone in People With Chronic Spinal Cord Injury (SCI) Previously Treated With Teriparatide Alendronate, Calcium, Vitamin D - Spinal Cord Injury, Bone Loss | Phase 2 | Completed | Northwestern University | 17 | 2014-04-01 | 2023-03-30 |
| Tepilta® Versus Oxetacaine, Antacids and Placebo oxetacaine, aluminium and magnesium hydroxide, oxetacaine, magnesium and aluminium hydroxide - Radiation-induced Oesophagitis | Phase 3 | Terminated | MEDA Pharma GmbH & Co. KG | 40 | 2011-04-01 | 2022-02-07 |
| Symptomatic Relief of Acute Dyspeptic Pain in Emergency Department With Pantoprazole Normal saline, Pantoprazole, Oral antacid - Dyspepsia, Emergency | Phase 4 | Completed | Chulalongkorn University | 87 | 2011-01-01 | 2013-09-18 |
| Effect of Food and Antacid on BIIB021 With Advanced Solid Tumors BIIB021 and Food, BIIB0121 and Antacid - Advanced Solid Tumors | Phase 1 | Completed | Biogen | 20 | 2009-11-01 | 2013-09-16 |
| Effect of Antacids on the Pharmacokinetics of Raltegravir raltegravir, antacid - HIV Infections | Phase 1 | Completed | University of Colorado, Denver | 17 | 2009-07-01 | 2017-06-28 |
| Effect of Antacids on Gleevec® in Healthy Volunteers Antacids (Mg-Al-based), Imatimib Mesylate (Gleevec®) - Healthy | Phase 1 | Completed | University of Pittsburgh | 12 | 2007-04-01 | 2016-06-22 |
| Nexium 40mg Once Daily vs Prevacid 30mg Twice a Day for Control of Severe GERD Antacids - GERD | Phase 4 | Completed | Digestive & Liver Disease Specialists | 50 | 2005-10-01 | 2009-02-25 |
Dyspepsia (2) · Gastroesophageal Reflux (2) · Acquired Immunodeficiency Syndrome (1) · Autism Spectrum Disorder (1) · Bone Diseases (1) · Bone Diseases, Metabolic (1) · Central Nervous System Diseases (1) · Constipation (1) · Diarrhea (1) · Digestive System Diseases (1) · Emergencies (1) · Esophageal Atresia (1) · Esophagitis (1) · Fractures, Bone (1) · HIV Infections (1)
Gut-Brain-Axis Therapeutics Inc. (2) · Alexion Pharmaceuticals, Inc. (1) · Alliance for Clinical Trials in Oncology (1) · Biogen (1) · Boston Children's Hospital (1) · Chulalongkorn University (1) · Digestive & Liver Disease Specialists (1) · Fondation Hôpital Saint-Joseph (1) · H. Lundbeck A/S (1) · MEDA Pharma GmbH & Co. KG (1) · Northwestern University (1) · Pfizer (1) · Stony Brook University (1) · University of Colorado, Denver (1) · University of Pittsburgh (1)
United States (12) · Austria (1) · France (1) · Germany (1) · Thailand (1) · United Kingdom (1)
David A Johnson, MD (1) · Frank Bruns, Dr. med. (1) · Jan H. Beumer, PharmD., PhD (1) · Jennifer J Kiser, PharmD (1) · Khrongwong Musikatavorn, MD (1) · Robert Miller, MD, MS (1) · Thomas J Schnitzer, MD, PhD (1) · Ursula Petzold, PhD (1)
2009 (1), U10CA037447 (1), UG1CA189823 (1)